中国学者近期发表的论文
1.	Design, synthesis, and evaluation of a series of novel phenylpropanoic acid derivatives agonists for the FFA1. Author: Yang J1, Gu E1, Yan T2, Shen D1, Feng B1, Tang C1. Journal: Chem Biol Drug Des. 2019 May;93(5):900-909. doi: 10.1111/cbdd.13480. Epub 2019 Jan 29.    PubMed      DOI
2.	Design, synthesis, and biological evaluation of 4-aminopyrimidine or 4,6-diaminopyrimidine derivatives as beta amyloid cleaving enzyme-1 inhibitors. Author: Xu X1, Lü P1, Wang J1, Xu F1, Liang L1, Wang C1, Niu Y1, Xu P1. Journal: Chem Biol Drug Des. 2019 May;93(5):926-933. doi: 10.1111/cbdd.13489. Epub 2019 Feb 12.    PubMed      DOI
3.	A combined drug discovery strategy based on machine learning and molecular docking. Author: Zhang Y1, Wang Y1, Zhou W1, Fan Y1, Zhao J1, Zhu L1, Lu S1, Lu T1,2, Chen Y1, Liu H1. Journal: Chem Biol Drug Des. 2019 May;93(5):685-699. doi: 10.1111/cbdd.13494. Epub 2019 Mar 7.    PubMed      DOI
4.	Synthesis and antitumor activity of 2-isocamphanyl thiosemicarbazone derivatives via ROS-enhanced mitochondria damage. Author: Wang Y1, Wang Z1, Kuang H1, Zhang Y1, Gu W1,2, Zhu Y3, Wang S1,2. Journal: Chem Biol Drug Des. 2019 Jan 28. doi: 10.1111/cbdd.13492. [Epub ahead of print]    PubMed      DOI
5.	Exploring binding mechanisms of VEGFR2 with three drugs lenvatinib, sorafenib, and sunitinib by molecular dynamics simulation and free energy calculation. Author: Wang Y1,2, Peng C2, Wang G2, Xu Z2, Luo Y1, Wang J2, Zhu W2. Journal: Chem Biol Drug Des. 2019 May;93(5):934-948. doi: 10.1111/cbdd.13493. Epub 2019 Feb 19.    PubMed      DOI
6.	Proteoliposome-based model for screening inhibitors targeting histidine kinase AgrC. Author: Zhang L1,2, Quan C1,2, Zhang X3, Xiong W1,2, Fan S1,2. Journal: Chem Biol Drug Des. 2019 May;93(5):712-723. doi: 10.1111/cbdd.13497. Epub 2019 Mar 13.    PubMed      DOI
7.	Molecular design of sequence-minimized, structure-optimized, and hydrocarbon-stapled helix-helix interactions in the trimer-of-hairpins motif of pediatric pneumonia RSV-F protein. Author: Wang J1, Zhang J1, Sun X1, Liu C1, Li X1, Chen L2. Journal: Chem Biol Drug Des. 2019 Feb 18. doi: 10.1111/cbdd.13501. [Epub ahead of print]    PubMed      DOI
8.	Computational insights into the interaction mechanisms of estrogen-related receptor alpha with endogenous ligand cholesterol. Author: Li D1, Cai Y1, Teng D1, Li W1, Tang Y1, Liu G1. Journal: Chem Biol Drug Des. 2019 Feb 27. doi: 10.1111/cbdd.13506. [Epub ahead of print]    PubMed      DOI
9.	Design, Synthesis and Evaluation of Novel Heteroaryldihydropyrimidines Derivatives as Non-nucleoside Hepatitis B Virus Inhibitors by Exploring the Solvent-exposed Region. Author: Yu J1, Guo X2, Desta S1, Zhang S1, Zhang J1, Ding X1, Liang X2, Jia H3, Liu X1, Zhan P1. Journal: Chem Biol Drug Des. 2019 Mar 1. doi: 10.1111/cbdd.13512. [Epub ahead of print]    PubMed      DOI
10.	Design and optimize N-substituted EF24 as effective and low toxicity NF-κB inhibitor for lung cancer therapy via apoptosis-to-pyroptosis switch. Author: Chen L1, Li Q1, Zheng Z1, Xie J1, Lin X2, Jiang C1, Xu H1, Wu X1,3, Wu J1, Zhang H1. Journal: Chem Biol Drug Des. 2019 Mar 15. doi: 10.1111/cbdd.13514. [Epub ahead of print]    PubMed      DOI

同类著名期刊名称 h-index CiteScore CELL 705 24.38 NATURE MEDICINE 497 19.14 Annual Review of Biochemistry 268 25.59 MOLECULAR CELL 356 11.82 Molecular Cancer 103 9.17 PROGRESS IN LIPID RESEARCH 132 11.75 TRENDS IN BIOCHEMICAL SCIENCES 253 11.69 TRENDS IN MICROBIOLOGY 172 7.85 Nature Chemical Biology 182 9.33 Molecular Plant 85 7.15

中科院JCR同大类学科的热搜期刊 浏览次数 MEDICINE 287596 CANCER RESEARCH 163771 International Journal of Nanomedicine 162223 Molecular Medicine Reports 162123 CANCER LETTERS 157294 JOURNAL OF ETHNOPHARMACOLOGY 139135 BIOMEDICINE & PHARMACOTHERAPY 137162 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 133786 Theranostics 133106 International Journal of Environmental Research and Public Health 131426